BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20660919)

  • 1. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan.
    Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan.
    Wang PN; Lirng JF; Lin KN; Chang FC; Liu HC
    Neurobiol Aging; 2006 Dec; 27(12):1797-806. PubMed ID: 16321457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
    Blom ES; Giedraitis V; Zetterberg H; Fukumoto H; Blennow K; Hyman BT; Irizarry MC; Wahlund LO; Lannfelt L; Ingelsson M
    Dement Geriatr Cogn Disord; 2009; 27(5):458-64. PubMed ID: 19420940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.
    Martínez MF; Martín XE; Alcelay LG; Flores JC; Valiente JM; Juanbeltz BI; Beldarraín MA; López JM; Gonzalez-Fernández MC; Salazar AM; Gandarias RB; Borda SI; Marqués NO; Amillano MB; Zabaleta MC; de Pancorbo MM
    BMC Neurosci; 2009 Sep; 10():125. PubMed ID: 19793392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
    Samaranch L; Cervantes S; Barabash A; Alonso A; Cabranes JA; Lamet I; Ancín I; Lorenzo E; Martínez-Lage P; Marcos A; Clarimón J; Alcolea D; Lleó A; Blesa R; Gómez-Isla T; Pastor P
    J Alzheimers Dis; 2010; 22(4):1065-71. PubMed ID: 20930301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.
    Boyle PA; Buchman AS; Wilson RS; Kelly JF; Bennett DA
    Neuroepidemiology; 2010; 34(1):43-9. PubMed ID: 19907191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
    Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
    Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCA7 gene and the risk of Alzheimer's disease in Han Chinese in Taiwan.
    Liao YC; Lee WJ; Hwang JP; Wang YF; Tsai CF; Wang PN; Wang SJ; Fuh JL
    Neurobiol Aging; 2014 Oct; 35(10):2423.e7-2423.e13. PubMed ID: 24908168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of four subtypes of mild cognitive impairment and APOE in a Japanese community.
    Sasaki M; Kodama C; Hidaka S; Yamashita F; Kinoshita T; Nemoto K; Ikejima C; Asada T
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1119-26. PubMed ID: 19449451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
    Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
    Chen Q; Wang T; Kang D; Chen L
    Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CSF GAP-43 and
    Zhu Y; Guo X; Zhu F; Zhang Q; Yang Y; For The Alzheimer's Disease Neuroimaging Initiative
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.
    Ma F; Wang J; Miao R; Zhao W; Wang Q
    Neuropsychobiology; 2011; 64(2):102-9. PubMed ID: 21701228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE ε4 positivity predicts centrality of episodic memory nodes in patients with mild cognitive impairment: A cohort-based, graph theory-informed study of cognitive networks.
    De Marco M; Wright LM; Valera Bermejo JM; Ferguson CE
    Neuropsychologia; 2024 Jan; 192():108741. PubMed ID: 38040087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.